PC
LLY icon

PointState Capital’s Eli Lilly LLY Stock Holding History

PointState Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,000
Closed -$4.14M – 103
2021
Q4 		$4.14M Buy
+15,000
New +$3.8M 0.07% 95
2020
Q4 		– Sell
-41,200
Closed -$6.1M – 145
2020
Q3 		$6.1M Buy
+41,200
New +$6.38M 0.16% 65

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PointState Capital's LLY Position: Q3 2022 in Review

PointState Capital sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 20,932 shares — an estimated $6.79M sold.

PointState Capital first reported a position in LLY in Q4 2014 and held it in 11 quarters. The position peaked at $108M in Q4 2014. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • PointState Capital reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
  • PointState Capital sold 20,932 Eli Lilly shares in Q3 2022, an estimated $6.79M.
  • PointState Capital first reported a position in Eli Lilly in Q4 2014 and held it in 11 quarters.
  • PointState Capital's Eli Lilly position peaked at $108M in Q4 2014.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on PointState Capital's 13F filing for Q3 2022, filed 10 Nov 2022.